Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency
Journal of Medicinal Chemistry · 11.05.2023 · 66 (9) · 6239-6250
DOI: 10.1021/acs.jmedchem.2c02076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.04.2023. Verfasst von Charu Chaudhry. Beteiligte Einrichtung: Molecular & Cellular Pharmacology, Lead Discovery, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477, United States. Hauptthemen laut MEDLINE: Proteolysis Targeting Chimera, Proteins. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Janssen Research and Development.
Abstract (Originalsprache)
Proteolysis targeting chimeras (PROTACs), heterobifunctional protein degraders, have emerged as an exciting and transformative technology in chemical biology and drug discovery to degrade disease-causing proteins through co-opting of the ubiquitin-proteasome system (UPS). Here, we develop a mechanistic mathematical model for the use of irreversible covalent chemistry in targeted protein degradation (TPD) either to a target protein of interest (POI) or an E3 ligase ligand, considering the thermodynamic and kinetic factors governing ternary complex formation, ubiquitination, and degradation through the UPS. We highlight key advantages of covalency to the POI and E3 ligase and the underlying theoretical basis in the TPD reaction framework. We further identify regimes where covalency can serve to overcome weak binary binding affinities and improve the kinetics of ternary complex formation and degradation. Our results highlight the enhanced catalytic efficiency of covalent E3 PROTACs and thus their potential to improve the degradation of fast turnover targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular & Cellular Pharmacology, Lead Discovery, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477, United States.
ORCID-Profile: Charu Chaudhry
Förderung
- Janssen Research and Development
Zitieren
APA
Chaudhry, C. (2023). Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency. Journal of Medicinal Chemistry, 66(9), 6239-6250. https://doi.org/10.1021/acs.jmedchem.2c02076
Vancouver
Chaudhry C. Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency. Journal of Medicinal Chemistry. 2023;66(9):6239-6250. doi:10.1021/acs.jmedchem.2c02076
BibTeX
@article{Chaudhry2023,
author = {Chaudhry, Charu},
title = {Mathematical Model for Covalent Proteolysis Targeting Chimeras: Thermodynamics and Kinetics Underlying Catalytic Efficiency},
journal = {Journal of Medicinal Chemistry},
year = {2023},
volume = {66},
number = {9},
pages = {6239--6250},
doi = {10.1021/acs.jmedchem.2c02076}
}
EUVIMED